SANUWAVE reported strong revenue growth and improved adjusted EBITDA, supported by increased UltraMIST sales and strong gross margins. However, decreased net income and increased operating expenses pose challenges. Despite these challenges, the company's expansion of its sales team and strategic growth initiatives signal a positive outlook.
Company Guidance
In the SANUWAVE Q2 2025 earnings call, the company provided guidance for Q3 revenues to be between $12 million and $12.7 million, acknowledging that it would be a tough comparison against the previous year's quarter, which saw an 89% year-on-year growth due to a significant one-time sale. Despite this, SANUWAVE maintained its annual guidance. The company reported strong financial performance in Q2 2025, with a 42% increase in revenue year-over-year, reaching $10.2 million. Gross margins improved to 78.3%, up from 73.2% the previous year. Operating income for the quarter was $1.9 million, and net income was $1.1 million, a decrease from $6.6 million in Q2 2024 due to previous non-cash gains and infrequent items. EBITDA stood at $3.2 million, with adjusted EBITDA improving to $3.4 million from $1.5 million the previous year. SANUWAVE also highlighted its focus on sustainable, profitable growth and strategic initiatives to drive further adoption of its UltraMIST systems.
Record Revenue Growth
SANUWAVE experienced a 42% year-over-year increase in revenue for Q2 2025, reaching a new quarterly record of $10.2 million. This growth was in line with previous guidance of 40% to 50%.
UltraMIST Sales Surge
The company sold 116 UltraMIST systems in Q2, a 61% increase from the previous year and an 18% increase from Q1 2025.
Strong Gross Margins
Gross margins remained strong at 78.3%, up 510 basis points from the previous year, highlighting successful cost management and strategic pricing.
Improved Adjusted EBITDA
Adjusted EBITDA for Q2 2025 was $3.4 million, an improvement of $1.9 million year-over-year.
Expansion of Sales Team
SANUWAVE expanded its sales team to include a full-time national and key accounts manager, enhancing their focus on larger accounts.
Sanuwave Health (SNWV) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
SNWV Earnings-Related Price Changes
Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Aug 08, 2025
$34.32
$39.76
+15.85%
May 09, 2025
$31.55
$30.10
-4.60%
Mar 21, 2025
$32.00
$37.61
+17.53%
Nov 08, 2024
$19.40
$22.20
+14.43%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Sanuwave Health (SNWV) report earnings?
Sanuwave Health (SNWV) is schdueled to report earning on Nov 07, 2025, TBA (Confirmed).
What is Sanuwave Health (SNWV) earnings time?
Sanuwave Health (SNWV) earnings time is at Nov 07, 2025, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.